ArunA Bio to Provide Corporate Update and Participate on a Panel at the 2019 BIO International Convention
Wednesday, May 22, 2019 05:43 PM

-- Panel Discussion Will Highlight Impact of Exosomes as Therapeutics and Drug Delivery Vehicles --

Athens, GA—May 22, 2019—ArunA Bio, Inc., a leader in the development of neural exosomes for the treatment of neurodegenerative diseases, today announced that Dr. Mark A. Sirgo, Chief Executive Officer, will lead a corporate presentation at the 2019 BIO International Convention occurring June 3-6, 2019 in Philadelphia, PA. Dr. Sirgo will provide an update on the company’s emerging pipeline and proprietary neural exosome drug delivery capabilities.

In addition, Dr. Steven Stice, Co-Founder and Chief Scientific Officer, will participate on a panel entitled “Harnessing the Potential of Exosomes”. The panel will explore the full potential of exosomes, and Dr. Stice will discuss the use of exosomes as both a therapeutic and a drug delivery vehicle.

Details of the Corporate Presentation:
Date: Tuesday, June 4, 2019
Time: 11:15-11:30 am ET
Location: Company Presentation Theater 2, Level 200, Philadelphia Convention Center

Details of the Panel:
Title: Harnessing the Potential of Exosomes
Date: Tuesday, June 4, 2019
Time: 3:15-4:15 pm ET
Location: 105AB, Level 100, Philadelphia Convention Center

About ArunA Bio

ArunA Bio is harnessing the natural abilities of neural exosomes to cross the blood brain barrier and enhance the body’s anti-inflammatory, self-repair and protective mechanisms to treat a range of neurodegenerative disorders. ArunA Bio is also leveraging its proprietary exosomes and manufacturing platform to create synergistic therapies by enhancing exosomes with RNA, oligonucleotides, antibodies and small molecules.


Lauren Arnold, 781-235-3060 [email protected]